. Author manuscript; available in PMC: 2015 Jun 1.

Published in final edited form as: Lancet Neurol. 2014 Apr 27;13(6):567–574. doi: 10.1016/S1474-4422(14)70066-3

Table 2.

Baseline and Clinical Features of Key IMS III Cohorts

	Endovascular Treated Arm		IV rt-PA Arm
	ICAT, M1, or M2 Occlusions on Baseline Angiography		ICAT, M1, or M2 Occlusions on Baseline CTA
	REPERFUSION COHORT	NO REPERFUSION COHORT
n	182¹	58²	83³
Age:Mean (SD)	66·2 (12·2)	65·6 (12·7)	67·4 (11·5)
NIHSS: Median (IQR)	18 (14–21)	17 (16–22)	17·5 (14–21)
ASPECTS >4 (%)[Exact 95% CI]	153 (85·5) [79·5–90·3]	48 (84·2) [72·1–92·5]	68 (81·9) [72·0–89·5]
mRS 0–2 (% ) [Exact 95% CI]	73 (40·1) [32·9–47·6]	6 (10·3) [3·9–21·2]	32 (38·6) [28·1–49·9]

1 subject missing NIHSS; 1 subject missing ASPECTS

3 subjects missing ASPECTS

1 subject missing NIHSS